{"id":"https://openalex.org/W1881925384","doi":"https://doi.org/10.1111/vco.12179","title":"Phase I lead\u2010in and subsequent randomized trial assessing safety and modulation of regulatory T cell numbers following a maximally tolerated dose doxorubicin and metronomic dose cyclophosphamide combination chemotherapy protocol in tumour\u2010bearing dogs","display_name":"Phase I lead\u2010in and subsequent randomized trial assessing safety and modulation of regulatory T cell numbers following a maximally tolerated dose doxorubicin and metronomic dose cyclophosphamide combination chemotherapy protocol in tumour\u2010bearing dogs","alternate_titles":[],"publication_year":2015,"publication_date":"2015-11-01","ids":{"openalex":"https://openalex.org/W1881925384","doi":"https://doi.org/10.1111/vco.12179","mag":"1881925384","pmid":"https://pubmed.ncbi.nlm.nih.gov/26522053"},"language":"en","primary_location":{"id":"doi:10.1111/vco.12179","doi":"https://doi.org/10.1111/vco.12179","is_oa":false,"landing_page_url":"https://doi.org/10.1111/vco.12179","pdf_url":null,"source":{"id":"https://openalex.org/S200673814","display_name":"Veterinary and Comparative Oncology","issn_l":"1476-5810","issn":["1476-5810","1476-5829"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","jufo-1","medline","norway-1","poland-200","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Veterinary and Comparative Oncology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W1881925384"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5015078870","display_name":"Rachel Rasmussen","orcid":"https://orcid.org/0000-0002-0264-6206","observed_orcids":["https://orcid.org/0000-0002-0264-6206"]},"institutions":[{"id":"https://openalex.org/I135310074","display_name":"University of Wisconsin\u2013Madison","ror":"https://ror.org/01y2jtd41","country_code":"US","type":"education","lineage":["https://openalex.org/I135310074"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"R. M. Rasmussen","raw_affiliation_strings":["Department of Medical Sciences, School of Veterinary Medicine, University of Wisconsin-Madison, Madison, WI, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Sciences, School of Veterinary Medicine, University of Wisconsin-Madison, Madison, WI, USA","institution_ids":["https://openalex.org/I135310074"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052093839","display_name":"Ilene D. Kurzman","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I135310074","display_name":"University of Wisconsin\u2013Madison","ror":"https://ror.org/01y2jtd41","country_code":"US","type":"education","lineage":["https://openalex.org/I135310074"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"I. D. Kurzman","raw_affiliation_strings":["Department of Medical Sciences, School of Veterinary Medicine, University of Wisconsin-Madison, Madison, WI, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Sciences, School of Veterinary Medicine, University of Wisconsin-Madison, Madison, WI, USA","institution_ids":["https://openalex.org/I135310074"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111757786","display_name":"Barbara J. Biller","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I92446798","display_name":"Colorado State University","ror":"https://ror.org/03k1gpj17","country_code":"US","type":"education","lineage":["https://openalex.org/I92446798"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"B. J. Biller","raw_affiliation_strings":["Flint Animal Cancer Center, Colorado State University, Fort Collins, CO, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Flint Animal Cancer Center, Colorado State University, Fort Collins, CO, USA","institution_ids":["https://openalex.org/I92446798"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087682489","display_name":"Amanda Guth","orcid":"https://orcid.org/0000-0001-9645-6528","observed_orcids":["https://orcid.org/0000-0001-9645-6528"]},"institutions":[{"id":"https://openalex.org/I92446798","display_name":"Colorado State University","ror":"https://ror.org/03k1gpj17","country_code":"US","type":"education","lineage":["https://openalex.org/I92446798"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"A. Guth","raw_affiliation_strings":["Flint Animal Cancer Center, Colorado State University, Fort Collins, CO, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Flint Animal Cancer Center, Colorado State University, Fort Collins, CO, USA","institution_ids":["https://openalex.org/I92446798"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5047472326","display_name":"David M. Vail","orcid":"https://orcid.org/0000-0002-1964-3693","observed_orcids":["https://orcid.org/0000-0002-1964-3693"]},"institutions":[{"id":"https://openalex.org/I135310074","display_name":"University of Wisconsin\u2013Madison","ror":"https://ror.org/01y2jtd41","country_code":"US","type":"education","lineage":["https://openalex.org/I135310074"]},{"id":"https://openalex.org/I4210103341","display_name":"University of Wisconsin Carbone Cancer Center","ror":"https://ror.org/01e4byj08","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I135310074","https://openalex.org/I2799905417","https://openalex.org/I4210103341","https://openalex.org/I4210132596"]}],"countries":["US"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"D. M. Vail","raw_affiliation_strings":["Department of Medical Sciences, School of Veterinary Medicine, University of Wisconsin-Madison, Madison, WI, USA","The Carbone Cancer Center, University of Wisconsin-Madison, Madison, WI, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Sciences, School of Veterinary Medicine, University of Wisconsin-Madison, Madison, WI, USA","institution_ids":["https://openalex.org/I135310074"]},{"raw_affiliation_string":"The Carbone Cancer Center, University of Wisconsin-Madison, Madison, WI, USA","institution_ids":["https://openalex.org/I135310074","https://openalex.org/I4210103341"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5047472326"],"corresponding_institution_ids":["https://openalex.org/I135310074","https://openalex.org/I4210103341"],"apc_list":{"value":4730,"currency":"USD","value_usd":4730},"apc_paid":null,"fwci":2.7525,"has_fulltext":false,"cited_by_count":18,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.88207861,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":97},"biblio":{"volume":"15","issue":"2","first_page":"421","last_page":"430"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11149","display_name":"Veterinary Oncology Research","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/3404","display_name":"Small Animals"},"field":{"id":"https://openalex.org/fields/34","display_name":"Veterinary"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11149","display_name":"Veterinary Oncology Research","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/3404","display_name":"Small Animals"},"field":{"id":"https://openalex.org/fields/34","display_name":"Veterinary"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T14072","display_name":"Immunotoxicology and immune responses","score":0.0006000000284984708,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11580","display_name":"Veterinary Medicine and Surgery","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/3404","display_name":"Small Animals"},"field":{"id":"https://openalex.org/fields/34","display_name":"Veterinary"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/doxorubicin","display_name":"doxorubicin","score":0.9049999713897705},{"id":"https://openalex.org/keywords/cyclophosphamide","display_name":"cyclophosphamide","score":0.9049999713897705},{"id":"https://openalex.org/keywords/metronomic-chemotherapy","display_name":"metronomic chemotherapy","score":0.8899999856948853},{"id":"https://openalex.org/keywords/regulatory-t-cells","display_name":"regulatory T cells","score":0.9769999980926514},{"id":"https://openalex.org/keywords/lymphodepletion","display_name":"lymphocyte depletion","score":0.8309999704360962},{"id":"https://openalex.org/keywords/chemotherapy-safety","display_name":"chemotherapy safety","score":0.5759999752044678},{"id":"https://openalex.org/keywords/dogs","display_name":"dogs","score":0.5830000042915344},{"id":"https://openalex.org/keywords/immunomodulation","display_name":"immunomodulation","score":0.7059999704360962},{"id":"https://openalex.org/keywords/combination-chemotherapy","display_name":"combination chemotherapy","score":0.5260000228881836}],"concepts":[{"id":"https://openalex.org/C2776755627","wikidata":"https://www.wikidata.org/wiki/Q408524","display_name":"Cyclophosphamide","level":3,"score":0.8169580698013306},{"id":"https://openalex.org/C2781303535","wikidata":"https://www.wikidata.org/wiki/Q18936","display_name":"Doxorubicin","level":3,"score":0.7663720846176147},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7656422853469849},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.6322715282440186},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.6288962960243225},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.5440253019332886},{"id":"https://openalex.org/C19831878","wikidata":"https://www.wikidata.org/wiki/Q659446","display_name":"Therapeutic index","level":3,"score":0.4623934030532837},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4461449980735779},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3234485387802124},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.15628033876419067}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D003520","descriptor_name":"Cyclophosphamide","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D003520","descriptor_name":"Cyclophosphamide","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D003520","descriptor_name":"Cyclophosphamide","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D004283","descriptor_name":"Dog Diseases","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D004283","descriptor_name":"Dog Diseases","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D004285","descriptor_name":"Dogs","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004317","descriptor_name":"Doxorubicin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D004317","descriptor_name":"Doxorubicin","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D004317","descriptor_name":"Doxorubicin","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000662","qualifier_name":"veterinary","is_major_topic":true},{"descriptor_ui":"D018655","descriptor_name":"Lymphocyte Count","qualifier_ui":"Q000662","qualifier_name":"veterinary","is_major_topic":false},{"descriptor_ui":"D050378","descriptor_name":"T-Lymphocytes, Regulatory","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D059250","descriptor_name":"Administration, Metronomic","qualifier_ui":"Q000662","qualifier_name":"veterinary","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1111/vco.12179","doi":"https://doi.org/10.1111/vco.12179","is_oa":false,"landing_page_url":"https://doi.org/10.1111/vco.12179","pdf_url":null,"source":{"id":"https://openalex.org/S200673814","display_name":"Veterinary and Comparative Oncology","issn_l":"1476-5810","issn":["1476-5810","1476-5829"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","jufo-1","medline","norway-1","poland-200","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Veterinary and Comparative Oncology","raw_type":"journal-article"},{"id":"pmid:26522053","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/26522053","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Veterinary and comparative oncology","raw_type":"Clinical Trial, Phase I"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9940000176429749,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":24,"referenced_works":["https://openalex.org/W34266163","https://openalex.org/W1546448788","https://openalex.org/W1613601325","https://openalex.org/W1924587196","https://openalex.org/W1971028719","https://openalex.org/W1973091654","https://openalex.org/W1975839407","https://openalex.org/W1982441587","https://openalex.org/W1996464576","https://openalex.org/W2034548257","https://openalex.org/W2043296164","https://openalex.org/W2049005197","https://openalex.org/W2059568170","https://openalex.org/W2067740246","https://openalex.org/W2070439776","https://openalex.org/W2087576209","https://openalex.org/W2114592067","https://openalex.org/W2126092906","https://openalex.org/W2142378149","https://openalex.org/W2155343550","https://openalex.org/W2169965478","https://openalex.org/W2169992085","https://openalex.org/W2585414498","https://openalex.org/W4205388838"],"related_works":["https://openalex.org/W2294528203","https://openalex.org/W1613601325","https://openalex.org/W1966955692","https://openalex.org/W3003212040","https://openalex.org/W2230204841","https://openalex.org/W1979235929","https://openalex.org/W2054330516","https://openalex.org/W2393661574","https://openalex.org/W1973091654","https://openalex.org/W2374691747"],"abstract_inverted_index":{"Maximally":[0],"tolerated":[1],"dose":[2,6],"(MTD)":[3],"and":[4,13,29,38,62,93,124,135,146],"metronomic":[5,30,125,147],"chemotherapeutic":[7],"approaches":[8],"alter":[9],"the":[10,14,73,114,133,137],"immune":[11],"system":[12],"angiogenic":[15],"process":[16],"in":[17,56,66],"different":[18],"yet":[19],"potentially":[20],"complementary":[21],"ways.":[22],"A":[23],"combination":[24,60,122],"of":[25,69,104,120,139,144],"MTD":[26,123,145],"doxorubicin":[27],"(MTD-DOX)":[28],"cyclophosphamide":[31],"(mCTX)":[32],"protocol":[33],"was":[34],"evaluated":[35],"for":[36,79],"safety":[37],"effect":[39,101],"on":[40],"circulating":[41,70],"regulatory":[42],"T":[43],"(Treg)":[44],"cells.":[45],"We":[46],"found":[47],"that":[48],"mCTX":[49],"can":[50],"be":[51],"safely":[52],"administered":[53],"with":[54],"MTD-DOX":[55],"tumour-bearing":[57],"dogs.":[58],"Both":[59],"DOX/mCTX":[61],"single-agent":[63],"DOX":[64,92,105],"resulted":[65],"significant":[67],"depletions":[68,84],"lymphocytes":[71],"throughout":[72],"chemotherapy":[74,148],"cycle":[75],"without":[76],"apparent":[77],"selectivity":[78],"Tregs.":[80],"The":[81],"indiscriminant":[82],"lymphocyte":[83],"were":[85],"similar":[86],"between":[87],"dogs":[88,94],"randomized":[89,95],"to":[90,96,113,131],"receive":[91,97],"DOX/mCTX,":[98],"suggesting":[99],"this":[100],"is":[102],"because":[103],"alone.":[106],"These":[107],"findings":[108],"may":[109],"have":[110],"implications":[111],"as":[112],"therapeutic":[115],"benefit":[116],"(or":[117],"lack":[118],"thereof)":[119],"concurrent":[121,140],"protocols.":[126,149],"Future":[127],"investigations":[128],"are":[129],"required":[130],"determine":[132],"effects":[134],"indeed":[136],"efficacy":[138],"versus":[141],"sequential":[142],"applications":[143]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W1881925384","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":4},{"year":2016,"cited_by_count":1},{"year":2014,"cited_by_count":1}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
